Global Retirement Partners LLC Makes New $4.21 Million Investment in UnitedHealth Group Incorporated $UNH

Global Retirement Partners LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 13,492 shares of the healthcare conglomerate’s stock, valued at approximately $4,209,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC lifted its holdings in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Ted Buchan & Co boosted its stake in shares of UnitedHealth Group by 4.0% in the 1st quarter. Ted Buchan & Co now owns 5,900 shares of the healthcare conglomerate’s stock valued at $3,090,000 after purchasing an additional 229 shares in the last quarter. Texas Yale Capital Corp. boosted its position in UnitedHealth Group by 17.6% in the first quarter. Texas Yale Capital Corp. now owns 2,517 shares of the healthcare conglomerate’s stock valued at $1,318,000 after buying an additional 377 shares in the last quarter. Finally, Sterling Investment Advisors Ltd. increased its holdings in UnitedHealth Group by 27.7% in the 1st quarter. Sterling Investment Advisors Ltd. now owns 576 shares of the healthcare conglomerate’s stock worth $302,000 after purchasing an additional 125 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $318.89 on Tuesday. The stock has a market capitalization of $288.86 billion, a price-to-earnings ratio of 16.64, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a fifty day moving average of $344.10 and a 200-day moving average of $315.39. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the business posted $7.15 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent analyst reports. Leerink Partners set a $410.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Piper Sandler reduced their target price on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.